Table 3 Histopathology of malignant and benign nodules
From: Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
HP of malignant nodules (n = 147) | Number of nodules (%) |
|---|---|
Adenocarcinoma | 59 (40) |
Squamous cell carcinoma | 40 (27) |
Large cell cancer | 11 (7.5) |
Carcinoid tumor | 11 (7.5) |
Non-specified NSCLC | 9 (6.1) |
Small cell lung cancer | 8 (5.4) |
Other | 9 (6.1) |
HP of benign nodules (n = 55) | |
Non-specified benign | 10 (18) |
Fibrosis-elastosis | 9 (16) |
Chronic inflammation | 7 (13) |
Lymphoid tissue hyperplasia | 4 (7.2) |
Squamous metaplasia 4 | 4 (7.2) |
Granuloma | 3 (5.5) |
Atypical cytology | 3 (5.5) |
Tuberculosis | 3 (5.5) |
Rheumatoid nodules | 2 (3.6) |
Silicoanthracotic nodules | 2 (3.6) |
Cryptococcus infection | 2 (3.6) |
Other | 6 (11) |